Shuttle Pharmaceuticals released FY2025 Q2 earnings on 2025-08-13 EST: Actual Revenue USD 0, Actual EPS USD -32.9156

Brief Summary

Shuttle Pharmaceuticals reported a net loss of $3.71 million with zero revenue and an EPS of -$32.92 for the second quarter of 2025 on August 13, 2025.

Impact of The News

Event Overview